Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Couch

Showing results (421-430 of 697) with videos related to

Pageof 70
Sort By:
The Lancet. Oncology|July 3, 2025
Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative GroupKatie M O'Brien, Melissa G House, Mandy Goldberg, et al.
NPJ Breast Cancer|July 13, 2024
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancerPeter A Fasching, Chunling Hu, Steven N Hart, et al.
European Journal of Human Genetics : EJHG|February 2, 2017
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.
Bioengineering (Basel, Switzerland)|November 27, 2025
Development of a Machine Learning Model for Predicting Treatment-Related Amenorrhea in Young Women with Breast CancerLong Song, Zobaida Edib, Uwe Aickelin, et al.
Breast Cancer Research and Treatment|February 21, 2013
A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replicationRebecca Hein, Dieter Flesch-Janys, Norbert Dahmen, et al.
Breast Cancer Research : BCR|April 20, 2012
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriersAna-Teresa Maia, Antonis C Antoniou, Martin O'Reilly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2017
Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based OutreachGoli Samimi, Marcus Q Bernardini, Lawrence C Brody, et al.
Nature Genetics|February 1, 2011
Common variants in ZNF365 are associated with both mammographic density and breast cancer riskSara Lindström, Celine M Vachon, Jingmei Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2021
Mutations in <i>BRCA1/2</i> and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on PrognosisPeter A Fasching, Siddhartha Yadav, Chunling Hu, et al.
Breast Cancer Research : BCR|May 24, 2019
Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer riskCeline M Vachon, Christopher G Scott, Rulla M Tamimi, et al.
Pageof 70

Showing results (421-430 of 697) with videos related to

Sort By:
Pageof 70
The Lancet. Oncology|July 3, 2025
Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative GroupKatie M O'Brien, Melissa G House, Mandy Goldberg, et al.
NPJ Breast Cancer|July 13, 2024
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancerPeter A Fasching, Chunling Hu, Steven N Hart, et al.
European Journal of Human Genetics : EJHG|February 2, 2017
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.
Bioengineering (Basel, Switzerland)|November 27, 2025
Development of a Machine Learning Model for Predicting Treatment-Related Amenorrhea in Young Women with Breast CancerLong Song, Zobaida Edib, Uwe Aickelin, et al.
Breast Cancer Research and Treatment|February 21, 2013
A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replicationRebecca Hein, Dieter Flesch-Janys, Norbert Dahmen, et al.
Breast Cancer Research : BCR|April 20, 2012
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriersAna-Teresa Maia, Antonis C Antoniou, Martin O'Reilly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2017
Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based OutreachGoli Samimi, Marcus Q Bernardini, Lawrence C Brody, et al.
Nature Genetics|February 1, 2011
Common variants in ZNF365 are associated with both mammographic density and breast cancer riskSara Lindström, Celine M Vachon, Jingmei Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2021
Mutations in <i>BRCA1/2</i> and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on PrognosisPeter A Fasching, Siddhartha Yadav, Chunling Hu, et al.
Breast Cancer Research : BCR|May 24, 2019
Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer riskCeline M Vachon, Christopher G Scott, Rulla M Tamimi, et al.
Pageof 70